Hadders-Algra, M., Heineman, K. R., Bos, A. F., &
Middelburg, K. J. (2010). The assessment of minor
neurological dysfunction in infancy using the Touwen
Infant Neurological Examination: strengths and
limitations. Developmental Medicine & Child
Neurology, 52(1), 87–92. https://doi.org/10.1111/
J.1469-8749.2009.03305.X
Hediger, M. L., Overpeck, M. D., Ruan, W. J., & Troendle,
J. F. (2002). Birthweight and gestational age effects on
motor and social development. Paediatric and Perinatal
Epidemiology, 16(1), 33–46. https://doi.org/10.1046/
j.1365-3016.2002.00393.x
Heimler, R., & Sasidharan, P. (2010). Neurodevelopmental
and audiological outcome of healthy term newborns with
moderately severe non-haemolytic hyperbilirubinemia.
Journal of Paediatrics and Child Health, 46(10), 588–
591. https://doi.org/10.1111/J.1440-1754.2010.01800.X
Johnson, L., & Bhutani, V. K. (2011). The Clinical
Syndrome of Bilirubin-Induced Neurologic
Dysfunction. Seminars in Perinatology, 35(3), 101–
113. https://doi.org/10.1053/j.semperi.2011.02.003
Kathrein, J. E. (1990). Interrater reliability in the
assessment of muscle tone of infants and children.
Physical and Occupational Therapy in Pediatrics, 10(1),
27–41. https://doi.org/10.1080/J006V10N01_04
Keren, R., Luan, X., Friedman, S., Saddlemire, S., Cnaan,
A., & Bhutani, V. K. (2008). A comparison of
alternative risk-assessment strategies for predicting
significant neonatal hyperbilirubinemia in term and
near-term infants. Pediatrics, 121(1). https://doi.org/
10.1542/PEDS.2006-3499
Khalaf, S. Y. A., O’Neill, S. M., O’Keeffe, L. M.,
Henriksen, T. B., Kenny, L. C., Cryan, J. F., &
Khashan, A. S. (2015). The impact of obstetric mode of
delivery on childhood behavior. Social Psychiatry and
Psychiatric Epidemiology, 50(10), 1557–1567.
https://doi.org/10.1007/S00127-015-1055-9
Kostović, I., & Judaš, M. (2007). Transient patterns of
cortical lamination during prenatal life: do they have
implications for treatment? Neuroscience and
Biobehavioral Reviews, 31(8), 1157–1168.
https://doi.org/10.1016/J.NEUBIOREV.2007.04.018
Lazić, L., Spalević, M., Zlatanović, D., Stanković, A., &
Marinković, O. (2011). Habilitation treatment of
hypertonia in newborns and infants. Acta Medica
Medianae, 50(1), 22–25. https://doi.org/10.5633/
AMM.2011.0104
Leyenaar, J. A., Camfield, P., & Camfield, C. (2005). A
schematic approach to hypotonia in infancy. Paediatrics
& Child Health, 10(7), 397–400. https://doi.org/10.
1093/PCH/10.7.397
Lindahl, E., Michelsson, K., Helenius, M., & Parre, M.
(1988). NEONATAL RISK FACTORS AND LATER
NEURODEVELOPMENTAL DISTURBANCES.
Developmental Medicine & Child Neurology, 30(5),
571–589. https://doi.org/10.1111/J.1469-8749.1988.
TB04795.X
Linder, N., Tsur, M., Kuint, J., German, B., Birenbaum, E.,
Mazkereth, R., Lubin, D., Reichman, B., & Barzilai, A.
(1998). A simple clinical test for differentiating
physiological from pathological head lag in full-term
newborn infants. European Journal of Pediatrics, 157(6),
502–504. https://doi.org/10.1007/S004310050863
Newman, T. B., & Klebanoff, M. A. (1993). Neonatal
hyperbilirubinemia and long-term outcome: another
look at the Collaborative Perinatal Project. Pediatrics,
92(5), 651–657. https://doi.org/10.1542/peds.92.5.651
Peredo, D., Review, M. H.-P. in, & 2009, undefined.
(2009). The Floppy InfantEvaluation of Hypotonia.
Publications.Aap.Org. https://doi.org/10.1542/pir.30-
9-e66
Prechtl, H. F. R. (2001). General movement assessment as
a method of developmental neurology: new paradigms
and their consequences. The 1999 Ronnie MacKeith
lecture. Developmental Medicine and Child Neurology,
43(12), 836. https://doi.org/10.1017/S00121622010 015
29
Rose, J., & Vassar, R. (2015). Movement disorders due to
bilirubin toxicity. Seminars in Fetal & Neonatal
Medicine, 20(1), 20–25. https://doi.org/10.1016/
J.SINY.2014.11.002
Sanger, T. D., Delgado, M. R., Gaebler-Spira, D., Hallett,
M., & Mink, J. W. (2003). Classification and definition
of disorders causing hypertonia in childhood. Pediatrics,
111(1), e89–e97. https://doi.org/10.1542/PEDS.111.1 .E
89
Sarici, S. Ü., Serdar, M. A., Korkmaz, A., Erdem, G., Oran,
O., Tekinalp, G., Yurdakök, M., & Yigit, S. (2004).
Incidence, course, and prediction of hyperbilirubinemia
in near-term and term newborns. Pediatrics, 113(4),
775–780. https://doi.org/10.1542/PEDS.113.4.775
Shapiro, S. M. (2003). Bilirubin toxicity in the developing
nervous system. Pediatric Neurology, 29(5), 410–421.
https://doi.org/10.1016/J.PEDIATRNEUROL.2003.09
.011
Soorani-Lunsing, I., Woltil, H. A., & Hadders-Algra, M.
(2001). Are moderate degrees of hyperbilirubinemia in
healthy term neonates really safe for the brain?
Pediatric Research, 50(6), 701–705. https://doi.org/
10.1203/00006450-200112000-00012
Soorani-Lunsing, I., Woltil, H., Research, M. H.-A.-P., &
2001, undefined. (n.d.). Are moderate degrees of
hyperbilirubinemia in healthy term neonates really safe
for the brain? Nature.Com.
Wusthoff, C. J., & Loe, I. M. (2015). Impact of bilirubin-
induced neurologic dysfunction on neurodevelopmental
outcomes. Seminars in Fetal and Neonatal Medicine,
20(1), 52–57. https://doi.org/10.1016/j.siny.2014.12.003
Zaigham, M., Hellström-Westas, L., Domellöf, M., &
Andersson, O. (2020). Prelabour caesarean section and
neurodevelopmental outcome at 4 and 12 months of age:
an observational study. BMC Pregnancy and Childbirth,
20(1). https://doi.org/10.1186/S12884-020-03253-8
Zhang, T., Brander, G., Mantel, A., Kuja-Halkola, R.,
Stephansson, O., Chang, Z., Larsson, H., Mataix-Cols,
D., & Fernández De La Cruz, L. (2021). Assessment of
Cesarean Delivery and Neurodevelopmental and
Psychiatric Disorders in the Children of a Population-
Based Swedish Birth Cohort. JAMA Network Open,
4(3). https://doi.org/10.1001/jamanetworkopen.2021.
0837n.